Cite
CD4, CD8 and PD1 immunoexpression in oral premalignant lesions (PML) and oral squamous cell carcinoma (OSCC) and its association with malignant transformation
MLA
João Marcos Arantes Soares, et al. “CD4, CD8 and PD1 Immunoexpression in Oral Premalignant Lesions (PML) and Oral Squamous Cell Carcinoma (OSCC) and Its Association with Malignant Transformation.” Journal of Clinical Oncology, vol. 36, Feb. 2018, p. 113. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........c8cc114581cbbae27958b493086eb396&authtype=sso&custid=ns315887.
APA
João Marcos Arantes Soares, Gabriele F Lopes, Eddie F.C Murta, Alexandre Barbosa Andrade, Adriano Mota Loyola, Hélio Batista dos Santos, Rosy Iara Maciel de Azambuja Ribeiro, Aline Lauda Freitas Chaves, Ana Gabriela Silva, Leandro A. Barbosa, Marcia A Michellin, Luiz Fernando B Paula, Flávia Medeiros Maia, & Luciana Vieira Muniz. (2018). CD4, CD8 and PD1 immunoexpression in oral premalignant lesions (PML) and oral squamous cell carcinoma (OSCC) and its association with malignant transformation. Journal of Clinical Oncology, 36, 113.
Chicago
João Marcos Arantes Soares, Gabriele F Lopes, Eddie F.C Murta, Alexandre Barbosa Andrade, Adriano Mota Loyola, Hélio Batista dos Santos, Rosy Iara Maciel de Azambuja Ribeiro, et al. 2018. “CD4, CD8 and PD1 Immunoexpression in Oral Premalignant Lesions (PML) and Oral Squamous Cell Carcinoma (OSCC) and Its Association with Malignant Transformation.” Journal of Clinical Oncology 36 (February): 113. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........c8cc114581cbbae27958b493086eb396&authtype=sso&custid=ns315887.